Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07258433 · ClinicalTrials.gov registry record · NA
Effects of PeptiSleep on Sleep Quality in Healthy Adults
A NA study of Sleep and Healthy Participants, sponsored by Nuritas.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07258433: Recruiting NA study of Sleep and Healthy Participants, sponsored by Nuritas.
NCT07258433 is a NA study of Sleep and Healthy Participants that is actively recruiting participants, run by Nuritas. The registered enrollment target is 120 participants, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07258433, a NA study of Sleep and Healthy Participants, is actively recruiting participants, sponsored by Nuritas.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
Examining the effects of PeptiSleep, a plant-based sleep aid, on sleep quality in healthy adults
Primary Outcome
Change from baseline to the end of the study period in Sleep Quality via Leeds Sleep Evaluation Questionnaire (LSEQ). The LSEQ comprises ten self-rating 100-mm-line analogue questions concerned with aspects of sleep and early morning behaviour. A visual analogue scale is used with two extreme states defined at the ends of the line (e. g. Tired = score of 0, Alert = score of 10). The subject responds by placing a vertical mark on the line to indicate his present self- evaluation. The four subsca
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT PeptiSleep
- DIETARY_SUPPLEMENT Micro-crystalline cellulose
Study Locations (1)
Delaware
- Reputable Labs Inc. - Wilmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-12-29 |
| Est. Completion | 2026-03-28 |
| Phase | NA |
What NCT07258433 shows while recruiting
NCT07258433 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 4,165-participant average among 151 other Sleep trials with a reported enrollment target (97% lower).
The record links to 5 conditions, with Sleep appearing as the primary indexed condition, and to 2 interventions - of which PeptiSleep is the first listed.
NCT07258433 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT07258433 about?
NCT07258433 is a clinical study titled "Effects of PeptiSleep on Sleep Quality in Healthy Adults". Examining the effects of PeptiSleep, a plant-based sleep aid, on sleep quality in healthy adults
What is the current status of trial NCT07258433?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-12-29. Estimated completion is 2026-03-28.
What conditions does trial NCT07258433 study?
This clinical trial studies the following conditions: Sleep, Healthy Participants, Cortisol, Wearable Technology, Cognitive Abilities.
What interventions are being tested in trial NCT07258433?
The interventions under investigation include: PeptiSleep (DIETARY_SUPPLEMENT), Micro-crystalline cellulose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07258433?
This trial is sponsored by Nuritas, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07258433 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07258433's enrollment target sits among peer trials
120 47th of 151 higher than 101 of 151 other Sleep trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Student Exercise and Sleep Timing Study - Part 2
RECRUITING · NA
-
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
RECRUITING · NA
-
The Goodnight Screen Media Study
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
The Iowa ACEs and Sleep Cohort and Manipulating Sleep in Young Adults With ACEs Studies
RECRUITING · NA
-
Shifting Sleep Timing in Teens
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI